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MOTIVATIONAL INTERVIEWING FOR VACCINE HESITANT PARENTS 
MEREDITH JOHNSON 
ABSTRACT 
Background 
The widespread use of vaccines led to significant decline in multiple potentially fatal 
infectious diseases. Recently, there has been an increase in vaccine hesitancy. Measles 
and pertussis outbreaks throughout the United States have put a spotlight on this urgent 
healthcare issue. Motivational interviewing is a counseling tactic that is gaining 
popularity and is being studied for its efficacy in preventative medicine and 
psychological disorders. It aims to inspire people to make behavioral changes through 
collaborative relationships with their provider by understanding how current actions do 
not translate into their health goals. 
Literature review findings 
Vaccine hesitancy is growing. Communities with decreased immunization rates are 
associated with a higher risk of disease outbreak. Increasing rates of undervaccinated 
children are likely due to increases in non-medical exemptions. Many parents, regardless 
of their vaccine hesitancy status, are concerned about vaccine safety. Vaccine hesitant 
parents refuse vaccines due to philosophical and religious beliefs, conspiracy theories, 
and safety concerns. Parents feel that providers do not adequately address their concern. 
Providers report not having the training to discredit parental concerns. The majority of 
parents describe their child’s pediatrician as their most trusted source of vaccine 
information. Parents who receive vaccine information from a provider are more likely to 
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comply with the recommended childhood vaccine schedule. The most efficient way to 
discuss vaccines with parents has yet to be determined.  
Proposed project 
This is a proposed QI research project for the Pediatric Clinic at Boston Medical Center. 
Providers would be trained in motivational interviewing during several sessions that 
included lectures and small group practice sessions with systematic feedback. During the 
intervention, parents who refuse vaccines for their child, aged 0-6 years old, will receive 
motivational interviewing from the provider. The proportion of the vaccine hesitant 
parents who accept the offered vaccine after will be analyzed. The pre and post 
intervention vaccination rates for the entire clinic will also be assessed. Data collection 
will be preformed through retrospective chart review. The project aims to increase 
provider confidence on vaccine counseling, educate providers on reasons for hesitancy, 
and improve compliance with the CDC recommended vaccine schedule.	   
Conclusion 
While most Americans continue to vaccinate their children according to the CDC’s 
recommended schedule, constant vigilance is required to maintain high immunization 
rates to protect our communities. Motivational interviewing is goal-oriented to alter a 
specific behavior and would allow providers to engage in an open, persuasive dialogue 
about parental vaccine concerns.  
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INTRODUCTION 
Background 
Vaccines have proven to be one of the most successful healthcare interventions by 
decreasing the spread of infectious disease.1,2 The use of vaccines has reduced the 
incidence of several potentially fatal infectious illnesses worldwide including, but not 
limited to, small pox, polio, measles, and Haemophilus influenzae type b (Hib).1 There 
are currently seventeen vaccine preventable diseases (VPDs) as a result of immunizations 
administered to children and adults.3 
It is estimated that during the lifetime of children born between 1994 and 2013 
vaccinations will prevent an estimated 322 million illness, 21 million hospitalizations, 
and 732,000 deaths by the Center for Disease Control and Prevention (CDC) in the 
United States (U.S.).4 The CDC currently recommends nine childhood vaccines during a 
child’s first 6 years of life with the goal of providing children lifelong immunity to most 
of these pathogens.4,5 (Appendix) 
Over the past 15 years, refusal of these potentially life saving vaccines has increased, 
leading to the emergence of VPDs.6 When VPD rates were high, the fear of the illness 
provided motivation to vaccinate a child.6 Due to the widespread use of vaccines, and the 
resulting decrease in occurrence of these diseases most Americans have not been exposed 
to the devastating effects these diseases can have on children.1,4,7 The result has been a 
shift in fear of disease to fear of the vaccine.1,4,7	  
	  2 
Statement of the Problem 
Vaccine hesitancy is defined as the delay in acceptance or refusal of vaccines despite 
availability of vaccination services by the Strategic Advisory Group of Experts (SAGE), 
an advisory group for the World Health Organization (WHO) on immunizations and 
vaccine preventable illnesses.8 Vaccine hesitant parents (VHPs) are a heterogeneous 
group, presenting with a large variety of beliefs toward vaccines and the recommended 
vaccination schedule.8,9 The myth about the development of autism from the MMR 
vaccine is most publically known due to social media and celebrity campaigning.10 VHPs 
state religious and philosophical beliefs, safety concerns, government and pharmaceutical 
conspiracies, and ambiguity aversion as reasons for refusal.1,11,12 The philosophical 
beliefs held by VHPs include the following: natural immunity is better than an artificial 
or man-made immunity, children receive too many vaccinations during one visit, and 
reliance on herd immunity to protect the child.11 Ambiguity aversion occurs when an 
individual prefers to take a known risk, such as contracting disease, rather than an 
unknown risk, such as the potential side effects of a vaccine.1 VHPs may underimmunize 
their child by personally selecting which vaccines they believe their child needs, use an 
alternate vaccination schedule, or refuse all recommended vaccines.9  
 Parents who choose to not vaccinate their children according to the CDC’s 
recommended immunization schedule put their child at a higher risk of becoming 
infected with a VPD.13 The increasing rate of undervaccinated children has led to the 
increased risk of transmitting a VPD as well.1 For example, in 2000, the U.S. was thought 
to have eradicated the endemic transmission of measles, but since then, the U.S. has had 
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numerous outbreaks attributed to the decreased vaccination rate.1,13, 14 In 2014, there was 
a record number of 667 measles cases.15,16 The cases were reported from 27 states during 
23 different outbreaks.15,16 Additionally, a highly publicized outbreak in California that 
was found to have originated at Disneyland in December 2015 infected 147 people.17 
According to the CDC’s review of this outbreak, over 80% of the people affected from 
January 2015 to April 2015 were unvaccinated, including infants, who are too young to 
be vaccinated, and children with true contraindications to vaccinations (Table 2).16 High 
vaccination rates are required in communities to protect those individuals who do not 
meet the criteria to be vaccinated.1  
 Providers have struggled to find efficient ways to discuss the advantages and 
necessity of vaccinations with VHPs.18,19 The era of “medical paternalism” is being 
replaced as people desire a shared decision making dynamic with their healthcare 
provider.1,19 The majority of parents continue to believe their child’s healthcare provider 
is the most influential source of information regarding vaccines and safety.1 Medical 
professionals have reported feeling they lack the training to discredit many of the anti-
vaccination messages parents have heard through social media, the internet, or from word 
of mouth.19 There is a need for specific attention to training medical professionals about 
vaccine hesitancy to allow them to be better prepared for these crucial conversations.20 
Appointment times are already rushed; therefore, there is no time to waste using 
ineffective approaches. To be successful in educating and discussing the importance of 
vaccines with parents, providers need to share effective strategies with each other as well. 
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While this is a heavily researched topic, frequent research and updating best practices 
should be done to ensure that providers do not fall behind on this evolving topic.21 
Motivational interviewing (MI) is defined as a “client centered yet directive 
method for enhancing intrinsic motivation to change by exploring and resolving client 
ambivalence.”23 It is a therapeutic approach that was first described by Carl Rogers over 
25 years ago.23, 24 This technique is gaining popularity as it has shown to be effective for 
counseling people who suffer from alcohol or substance abuse disorders.23 Healthcare 
professionals and researchers are hoping to use MI for other clinical problems, such as 
medication compliance, smoking cessation, weight loss, and several psychiatric 
illnesses.23  
 
Hypothesis 
Pediatric providers will increase vaccination rates and decrease vaccine hesitancy by 
implementing MI with vaccine hesitant parents after participating in an educational 
curriculum focused on vaccine hesitancy and MI training.  
 
Objectives and specific aims 
Vaccine hesitancy has created an opportunity for the healthcare community to become 
strong advocates for childhood vaccinations. To do this successfully, the reasons for 
refusal need to be thoroughly understood. Healthcare providers need to be able to 
effectively educate and communicate openly with parents without being judgmental. By 
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understanding the reasons for vaccine hesitancy, providers will be able to see both sides 
of the script and be more persuasive when discussing the importance of immunizations.  
The use of MI on VHP will be explored. One of the initial steps in MI is to 
appropriately assess the patient’s readiness to change.23 If the VHP is unwilling to change 
their mind, then the provider may waste valuable time. The technique can also be adapted 
to create personalized counseling by addressing the parent’s specific reason for refusal. 
The most valuable aspects are that MI allows the parent to engage in an open 
conversation with the medical provider and to be involved in the decision making.  
The specific goals for this proposal are as follows:    
1. To train providers in motivational interviewing 
2. To analyze the change in vaccination rates by measuring the proportion of VHPs 
who accept the offered vaccine after receiving MI  
3. To increase vaccination rates for the recommended childhood vaccines  
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REVIEW OF THE LITERATURE 
Overview 
Vaccinations have proven to be a major healthcare innovation, saving millions of lives 
since their creation (Table 1).1.6 Despite the effectiveness of vaccines, our society is 
experiencing an increase in vaccine hesitancy and refusal, resulting in undervaccination 
in many communities throughout the U.S.1, 13, 25, 26 
Table 1. Decrease in VPDs in the U.S. after Implementation of National 
Immunization Recommendations3 
 
Condition Annual Average 
Number of Pre-
vaccine Cases in 
U.S. 
Number of 
Cases 
Reported in 
2012a 
Reduction (%) in 
Cases After 
Widespread 
Vaccination 
Smallpox 29, 005 0 100 
Diphtheria 21,053 1 99 
Measles 530,217 55 99 
Mumps 162,344 229 99 
Pertussis 200,752 48,277 76 
Polio (paralytic)  16,316 0 100 
Rubella 47,745 9 >99 
Congenital Rubella 
Syndrome 
152 2 99 
Tetanus 580 37 94 
Haemophilus influenzae 
type b infection 
20,000 30b 99 
Hepatitis A 117,333 2,890a 98 
Hepatitis B (acute) 66,232 18,800a 72 
Invasive pneumococcal 
infection (all ages) 
63,067 31,600 50 
Invasive pneumococcal 
infection (<5 years old) 
16,069 1,800 89 
Varicella  4,085,120 216,511 95 
a Except for hepatitis A and B, where 2011 figures are shown from CDC’s Viral 
Surveillance, 2011 
b An additional 13 type b infections are estimated to have occurred from the 210 H. 
influenzae infections of unknown type in children under age 5 years old.  
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Vaccines were created by Edward Jenner in 1796.27 Prior to his discovery, the 
process of variolation was used to create immunity from smallpox.27 Smallpox survivors 
appeared to be protected from recurrent infection.27 Researchers at the time attempted to 
make inoculations from the pus or scab of an infected individual.27 This process is called 
variolation.27 The procedure led to the transmission of a localized, less severe form of 
smallpox at the site of inoculation in some recipients and systemic smallpox infections in 
others.27 It was the only hope of protection against the smallpox endemics that continued 
to occur worldwide with devastating effects.27 In 1774, Benjamin Jesty, a farmer in 
England discovered the link between cowpox and smallpox.27 Jesty found that his two 
dairymaids, who had previously contracted cowpox, did not become infected with 
smallpox despite being exposed by several family members.27 He believed that exposure 
to cowpox provided immunity to smallpox.27 To test his theory, he successfully 
inoculated his wife and two sons with serum from cowpox lesions.27 Jenner, a physician 
in England, took Jesty’s hypothesis a step further.27 He performed an inoculation 
experiment on a healthy eight year old boy using the purulent material from a 
dairymaid’s cowpox sore. 27 The boy initially suffered from an acute cowpox infection.27 
After six weeks, Jenner variolated him using the standard procedure at the time.27 The 
boy had a localized reaction, but no constitutional symptoms, illustrating his immunity.27 
This was labeled the discovery of the first vaccine.27 Centuries and several revisions later, 
the smallpox vaccine globally eradicated smallpox as of December 1979.27 
Vaccines are biologic substances intended to provoke the immune system to 
create a neutralizing response against a specific target.28 They can protect individuals 
	  8 
from viral, bacterial, and toxin related illnesses.28 Some vaccines may decrease the 
severity of an infection, such as the rotavirus vaccine, or reduce the likelihood of an 
infection’s complications, such as the zoster vaccine for adults.3 Others reduce the 
transmission of infectious pathogens, leading to the protection of unimmunized people.3 
There are two main forms of immunization, active and passive. Active 
immunization occurs when an antigen is in the vaccine and the recipient’s immune 
system creates antibodies to the antigen, leading to cell mediated immunity.30 Active 
immunization aims to provide lifelong, or at least long-term immunity, and is therefore 
preferred over passive immunization.30 These vaccines may contain inactivated or live, 
attenuated viral or bacterial components, toxoids, subunits, or conjugate pathogens.28, 29, 
31 A live, attenuated vaccine contains a weakened form of the pathogen.29,31 An 
inactivated vaccine means the pathogen has been killed, so it can not replicate inside the 
recipient.31 Toxoid vaccines contain inactivated toxins.27 These toxins are emitted from 
bacterium and cause specific disease.29 For example, tetanus is caused by the neurotoxin 
released by Clostridium tetani bacteria, known as tetanospasmin.29 Therefore, to have 
immunity from this disease, the vaccine must create protection from the toxin, not the 
bacteria. Subunit vaccines use specific parts of the pathogen that will provoke the 
immune response.32 Conjugate vaccines are created with pieces of the pathogen 
biochemically linked to a carrier protein, which creates a stronger immune response by 
the host.32 The pneumococcal vaccine recommended for children uses the capsular 
polysaccharide of 13 streptococcus pneumonia serotypes.33 It is bound to a carrier 
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protein, the diphtheria toxoid, which allows the host’s immune system to mount a greater 
response to the vaccine, providing a higher level of protection.29  
 Passive immunization occurs when there is transfer of immunity with preformed 
immunologic products, known as immune globulins.30,34 This can be a natural process, 
such as the transfer of IgG across the placenta from mother to fetus, or therapeutic 
process, by administrating the immune globulins.34 Maternal IgG protection to the fetus 
only lasts six months after birth, which illustrates the child’s need for further protection 
through vaccines.34 Therapeutic passive immunization, such as in response to rabies, 
botulism, or tetanus exposure, may only last weeks to months and would theoretically 
require constant immunization to maintain protection.34  
Vaccines made with live attenuated virus can provide protection to the 
community as well.35 Herd immunity is defined as the resistance of a group against 
invasion and spread of an infectious agent as a result of a majority of people being 
immunized.7,35 It can be the result of natural immunity or immunization.35 The vaccine 
must alter the transmission of the virus by inducing IgA production to have this effect.35 
For example, the live polio vaccine provokes secretory IgA production in the gut, which 
prevents infection from virulent polio virus.35 The live attenuated virus in the polio 
vaccine replicates in the recipient, but not enough to cause the host to become ill.35 The 
replication process allows the live attenuated virus to be spread to other members of the 
community, eliciting protection to more individuals.35 Vaccines made with a killed or 
inactivated pathogen only protect the individual as no IgA is produced in response to the 
vaccine.35 The herd immunity threshold is the lowest proportion of individuals in a 
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community that need to be vaccinated to provide protection to the population.7 The 
threshold proportion is different for each vaccine and population. If the community meets 
the threshold percentage, then the members of that community have protection against 
the pathogen, including those who cannot get vaccinated due to medical contraindications 
(Table 2).7  
The CDC recommends that all children should be vaccinated according to the 
universal vaccine timeline (Appendix) provided by the CDC.4,5 The CDC recommends 
that vaccines which require multiple doses should not be administered early, but does 
allow a four day grace period for administration date.5,36 
 The contraindications should be reviewed before administering any vaccine. The 
only absolute contraindication that applies to all vaccines is the personal history of a 
severe allergic reaction, such as anaphylaxis after receiving a vaccination or after 
exposure to a vaccine component.36 Anaphylaxis due to a vaccine or component of the 
vaccine typically begins minutes after administration.36 Prodromal signs may include 
flushing, facial edema, urticaria, pruritus, angioedema, wheezing, or dyspnea.36 
Anaphylaxis is rare, occurring in one in one million doses of vaccines.37 Children who are 
immune compromised should not receive live, attenuated vaccines until immune status 
has returned to normal function.36 These children may receive inactivated vaccines.36 A 
child with a moderate to severe acute illness, with or without a fever, may still receive all 
vaccines.36 In such instances, it is reasonable to consider delaying vaccination until 
symptoms resolve.36 Children with a mild illness should continue to receive the 
recommended vaccinations according to the CDC’s schedule.36 The Advisory Committee 
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on Immunization Practices (ACIP) does not recommend the live attenuated influenza 
vaccine (LAIV) for the 2016 – 2017 season due to its low efficacy.36 The inactivated 
trivalent influenza vaccine (TIV) is recommended yearly for children over six months.36 
Table 2. Childhood Vaccine Contraindications36 
Vaccine Contraindications 
DTaP • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
• Encephalopathy with otherwise no known case, within 7 days of 
administration of previous dose of DTaP  
IPV • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
MMR • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
• Pregnancy 
• Known severe immunodeficiency such as hematologic and solid 
tumors, receiving chemotherapy, congenital immunodeficiency, long 
term immunosuppressive therapy, and those with HIV infection who 
are severely immune compromised  
Hib • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
Hepatitis 
B 
• Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
Hepatitis 
A  
• Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
Varicella  • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component 
• Known severe immunodeficiency such as hematologic and solid 
tumors, receiving chemotherapy, congenital immunodeficiency, long 
term immunosuppressive therapy, and those with HIV infection who 
are severely immune compromised 
TIV  • Severe allergic reaction (anaphylaxis) after previous dose or to 
vaccine component, including egg protein 
Rotavirus • Severe allergic reaction (anaphylaxis) after previous dose or to a 
vaccine component  
• Severe Combined Immunodeficiency 
PCV • Severe allergic reaction (anaphylaxis) after a dose of PCV7, PCV13, 
or any diphtheria toxoid containing vaccine or component of listed 
vaccine  
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Food allergies are rarely a determining factor in receiving childhood vaccines.37 
The influenza vaccine contains egg protein; therefore, children with a history of 
anaphylactic reaction after eating eggs should not receive this vaccine.37 The ACIP 
recommends that people who can tolerate lightly cooked eggs without a reaction can 
receive the LAIV.37 The measles and mumps vaccine viruses from the MMR vaccine are 
grown in chick embryo fibroblast tissue, but have been proven safe for people with egg or 
egg protein allergies.37 None of the recommended childhood vaccines contain gelatin, a 
common question for pediatricians.36 
A study by McCarthy et al. utilized the VSD to investigate the deaths of children 
aged 9 to 26 years old between January 1, 2005 and December 31, 2011 who received a 
vaccine within 30 days prior to death.38 VSD data from 6 healthcare sites were 
reviewed.38 There were 1100 deaths within 12 months of a vaccination.38 76 of these 
deaths fit the criteria of being within 30 days of a vaccination, but only 59 of the deaths 
had adequate medical records for review.38 A team of CDC physicians reviewed the cases 
and agreed on the causes of death.38 The team found that none of the deaths were 
associated with a vaccine related cause.38 The study discovered that 0 to 30 days after at 
least one vaccine, there was a reduced risk of death (RR =.57) due to non-external causes 
and in deaths due to all causes (RR= .72).38 All childhood vaccines were associated with 
relative risk ratios under 1, indicating a decreased risk.38 McCarthy et al. notes 
confounding bias is likely responsible because the majority of the study’s participants 
have comorbidities.38 The study focuses on adolescents and not children, but it is likely 
still generalizable in regard to the vaccines that crossover from the CDC’s childhood 
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recommended schedule to the adolescent recommended schedule. Larger sample sizes 
would be needed to adequately investigate each vaccine individually.38 
 
Barriers to vaccination  
Vaccine hesitancy is not the only reason parents do not vaccinate their children. A 
narrative study performed by Thompson et al. reviewed 43 studies to explore possible 
reasons for the gap in the rate of vaccine coverage in children.12 The study found five 
major nonsocio-demographic reasons (Table 3) that encompass all identified elements of 
vaccine uptake. 12 They are referred to as the “5As” and include access, affordability, 
awareness, acceptance, and activation.12 The study mostly reviewed articles from the 
U.S., United Kingdom, and Australia.12 Developed countries were highly represented in 
this study; therefore, the results are applicable to the U.S.12 The studies focused on 
several types of vaccinations, but a majority of the studies were based on MMR and 
influenza vaccines.12  
Table 3. Five Major Nonsocio-demographic Reasons for Vaccine Uptake12 
5As Definition 
Access The ability of individuals to be reached by, 
or to reach recommended vaccines 
Affordability The ability of individuals to afford 
vaccinations, both in terms of financial and 
non-financial costs (e.g. time) 
Awareness The degree to which individuals have 
knowledge of the need for, and availability 
of recommended vaccines and their 
objective benefits and risks 
Acceptance The degree to which individuals accept, 
question, or refuse vaccination 
Activation The degree to which individuals are nudged 
towards vaccination uptake  
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Each state in the U.S. has its own immunization laws for children entering school 
or daycare.25,39 To varying degrees, states permit different types of exemptions that allow 
children to continue to attend school or daycare without immunizations. VPD outbreaks 
are associated with higher exemption rates.39 Exemptions may qualify the child to not 
receive a specific vaccine or, in rare cases, all of the required vaccines.40 There are three 
types of exemptions, which include medical, religious, and philosophical.40 A medical 
exemption can occur when the administration of a vaccine would be dangerous for the 
child’s health.25 For example, a child with medical contraindications, such as undergoing 
chemotherapy or a history of anaphylaxis to the vaccine, would be able to receive a 
medical exemption.25 Another example of a medical exemption is proof of immunity, 
such as the documentation of the child’s varicella IgE antibody level.25 A religious 
exemption is allowed when the family’s religious belief system is not congruent with 
vaccinations.25 Lastly, there are philosophical exemptions. This is the most rare type 
allowed in the U.S., that is based on the parent’s personal beliefs.25 The reasons vary 
greatly, but may include fear of safety, distrust in the government’s monitoring of 
vaccines, and fear that vaccines may cause chronic disease.25 The laws and requirements 
regarding philosophical exemptions vary greatly among each state that allows them.41 In 
2016, all 50 states allow medical exemptions, 47 states allow religions exemptions, and 
17 states allow philosophical exemptions.40, 41 
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Vaccine hesitancy  
Vaccine hesitancy began alongside the creation of the first vaccine.9 Jenner’s smallpox 
vaccine sparked controversy in his community for several reasons.9,27 People were 
concerned about the risks verses the benefits of the disease.9 Others voiced concerns of 
bestiality, because the source of the smallpox vaccine was originally from cows.1 Still, 
others debated the ethics of the vaccine, whether it was a human’s right to change divine 
will and the notion of individual freedom against shared responsibility.1, 27,42  These 
concerns continued in the U.S. in the 1850s during the implementation of the smallpox 
vaccine.41  
Parents continue to be worried about the safety, ethics, and necessity of vaccines 
for their children.1, 6, 25, 26 People are concerned about the government’s role in individual 
health.41 The cause of the recent rise in vaccine hesitancy is multifactorial. The use of 
social media and wide availability of the Internet have likely contributed, because 
information is quickly spread, regardless of its validity.9 While the majority of parents in 
the U.S. continue to vaccinate their children, many parents have skewed information on 
the role and safety of vaccines.1,9 Vaccines have become victims of their own success.1 
As the incidence of VPDs decrease, people forget the devastating effects they have 
allowing the risk of vaccination to appear greater than the risk of disease.1,8, 25 
In 2009, the National Immunization Survey (NIS) conducted a random digit dial 
survey of parents with children aged 19 to 35 months which revealed that 39.8% of 
parents had delayed or refused at least one dose of a CDC recommended vaccine.43 In 
2003, the same study was performed and showed 21.8% of parents in this demographic 
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had delayed or refused vaccines.44 Another 25.8% of parents had delayed one or more 
doses, 8.2% refused one or more dose, and 5.8% of parents had both delayed and refused 
one or more dose of a vaccine.44  
VSD data based on ICD 9 codes and medical record reviews from 2004 to 2010 
performed by Glanz et al. illustrated that out of 323,247 children, 13% of children were 
under-vaccinated due to parental decision.45 A direct measure of vaccine hesitancy is 
monitoring the number of non-medical exemptions in schools.26 Parents must fill out 
paperwork and actively get these exemptions approved, likely indicating a high level of 
vaccine hesitancy.26  In the 2013 to 2014 school year, the median state level of non 
medical exemptions nationally was 1.7%.26 This number appears low and manageable; 
however, the data must be examined locally to see the true effect of underimmunization. 
In Washington State, 3.5% of children had non medical exemptions in the 2013 to 2014 
school year, with counties peaking at 9% and school districts reporting up to 30% to 50% 
of children with non medical exemptions.26 From 2005 to 2009, the percentage of 
exemptions in school children in Utah rose from 2.8% to 3.3%.25  
 
Consequences of vaccine hesitancy  
There are four major factors that increase VPD incidence.3 They include low rates of 
immunization, leading to an increase in the number of susceptible individuals, an 
alteration in the infectious agent allowing it to escape vaccine protection, waning vaccine 
induced immunity, and lastly, a localized large inoculum. 3  
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A review of published literature by Phadke et al. examined the association 
between vaccine delay or exemption and the epidemiology of measles and pertussis with 
recent outbreaks within the U.S.13 Literature on measles outbreaks was reviewed from the 
declaration of measles eradication on January 1, 2000 to November 30, 2015.13 The 
measles vaccine was introduced in 1963 and measles was declared eradicated from the 
U.S. in 2000.1,13,14 Strong immunization program efforts and the introduction of a second 
dose in 1990 led to this success.13,14 There was one case of measles per 1 million people 
in the U.S. in 1997 through 1999.2 Yet, due to declining vaccination rates, the United 
States continues to have cases from foreign transmission.1,13 Most often, researchers have 
found individuals acquire measles outside of the U.S. and introduce the pathogen into the 
community after returning home.1,13 Eighteen published measles studies were found with 
1416 documented measles cases.13 The age of individuals affected ranged from 2 weeks 
old to 84 years old, with 178 children under 12 months affected.13 Of those, 970 had 
known vaccination status.13 574 of the 970 cases were unvaccinated, but age eligible for 
vaccinations.13 Of the 575 unvaccinated individuals who had measles, 405 or 70.6% were 
unvaccinated with non-medical exemptions.13 Researchers also reviewed the cumulative 
epidemic curve, analyzing weekly transmission.13 Unvaccinated people made up a larger 
fraction of the total measles cases in the earliest weeks of the outbreak.13 Children who 
were not vaccinated against measles were found to have 35 times greater risk to contract 
measles compared to vaccinated children.13 In 2011, the majority of measles cases 
reported occurred in states that allow philosophical exemptions, such as Washington, 
California, Utah, Arizona, Texas, Minnesota, and Pennsylvania.41 
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Pertussis continues to be endemic in the U.S.13 Literature on pertussis outbreaks 
by Phadke et al. was reviewed from the point of lowest incidence, January 1, 1977 
through November 30, 2015.13 After the invention of the vaccine in 1940, there was a 
significant decrease in incidence.13 By 1976, only 1010 cases were reported in the U.S.13 
Since then, pertussis incidence has increased with over 10,000 cases reported each year 
for the past 10 years.13 In 2004, 25,827 cases were reported, the largest amount since 
1959.13 The increase in incidence was blamed on the switch from the whole cell to the 
acellular pertussis vaccine and the waning immunity found in older populations.13  
Thirty two articles were found on pertussis outbreaks with 10,609 people of 
known vaccination status affected.13 Ages involved ranged from 10 days old to 87 years 
old.13 During 2010, in California alone, 4,415 children, aged 6 months to 18 years old 
with known vaccination status were diagnosed with pertussis.13 Of those children, 45% or 
2001 children were not up to date on the associated age appropriate vaccine versus 
pertussis, DTaP.13 Again in California, in 2014, 222 children under the age of 1 year were 
diagnosed with pertussis.12 Over half of these children were age eligible to receive a dose 
of DTaP; yet, only 53 of the children had received at least one dose.13 Outbreaks of 
pertussis have been documented in Florida, Massachusetts, Arizona, Delaware, Oregon, 
and Washington.13 Analysis of these outbreaks showed high transmission to people with 
appropriate age recommended pertussis vaccine coverage.13 The cause was found to be 
waning immunity, illustrating the importance of booster immunizations in adult 
populations.13 It was estimated that individuals with an exemption to the DTaP vaccine 
are at a risk of 20 times greater than a vaccinated individual to get pertussis.13 
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Phadke et al also performed case reviews of 6 observational studies on pertussis 
outbreaks in the U.S. which have shown schools and communities with higher 
exemptions rates to have higher rates of pertussis, including among highly vaccinated 
population.13 The case review found states that allow philosophical exemptions have 
approximately a 1.5 elevated incidence of pertussis compared to states without 
philosophical exemptions.13 The potential loss of herd immunity puts an entire 
community, and possibly the state, at risk for a VPD outbreak.1,13 	   	  	  
Existing research  
Reasons parents refuse vaccines 
Over the past few decades several surveys have been performed to assess parental 
vaccine hesitancy. In 1999, a national telephone survey of parents with children under the 
age of 6, indicated that 87% of parents considered vaccination extremely important, 25% 
thought a child’s immune system could be weakened by too many immunizations at one 
visit, and 23% believed children receive too many immunizations.26,46 A similar survey of 
parents with children from one to six years old was performed in 2010 by the 2010 
HealthStyles Panel.26,47 The study showed 77% of parents had concerns about 
vaccines.26,47 Of these, 36% had concerns about receiving too many shots at one visit, 
30% were concerned about the risk of autism, 26% believed the ingredients were unsafe, 
and 17% did not believe vaccines were properly checked for safety in children.26,47  
In 2009, a HealthStyles consumer mail panel survey was used to research vaccine 
attitudes, concerns, and information sources utilized.48 Of the 4556 respondents, only the 
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475 with at least one child under the age of 6 were included in the study.48 74.5% of these 
parents reported their youngest child had already received all the CDC recommended 
vaccines and 18.9% reported they planned on vaccinating their child along with the 
recommended schedule.48 79% of those parents were confident or very confident in 
vaccine safety and 79.8% believed vaccines were important for children’s health.48 
However, 21.9% of parents did somewhat or strongly agree about the concern of 
overwhelming the child’s immune system.48 Parents were also asked to fill out a separate 
questionnaire of 11 potential vaccine concerns.48 The top concern was pain for the child 
at 44%.51 34.2% reported concern over too many vaccines in one appointment, 26.2% 
were concerned about the risk of autism, while 13.5% were concerned about other 
chronic illness caused by vaccines.48 22.1% and 13.2% were concerned about the 
ingredients in vaccines and whether vaccines were tested appropriately, respectively.48 
20.8% of parents reported they have no concerns about vaccines at all.48  
A review article by McKee and Bohannon discussed findings from 10 articles 
relating to reasons for vaccine hesitancy.11 Four major categories were identified as 
reasons for refusal, which include the following: religious reasons, personal or 
philosophical beliefs, safety concerns, and a desire for more information.11 Some parents 
believed their child would benefit from contracting vaccine preventable illnesses to allow 
their immune system to become stronger.11 Natural immunity to pathogens has not shown 
to be superior to vaccine acquired immunity.11 Other personal belief reasons included that 
VPDs are rare; therefore, the child has a low risk of coming in contact with an affected 
individual.11 Negative marketing on “processed” foods or synthetic materials has also 
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affected vaccine hesitancy, as many parents desire to use “natural” or “organic” 
products.4,26 The artificial composition of vaccines needs further explaining to parents 
who share this concern.26 Thimerosal, a preservative,  has been described as a significant 
toxin through the media as an agent that causes devastating side effects, such as autism, 
brain damage or developmental issues.50 After thimerosal was thoroughly researched, no 
such claims were proven.11.56 Researchers concluded that while high doses of thimerosal 
could potentially be dangerous, the extremely low levels found in the multi-dose vials of 
vaccines posed no risk.11,56 Nonetheless, thimerosal has been removed from all vaccines 
given to children under the age of 6 years old, except for a trace amount in the Trivalent 
Influenza Vaccine (TIV).10, 50 Parents also report concerns about children receiving too 
many vaccinations in one appointment for fear of overworking the child’s immune 
system.11 Parents in this category often have minimal education on how the immune 
system operates and that all humans are exposed to thousands of pathogens daily.11 
 In a case control study by Salmon et al. of parents in Colorado, Massachusetts, 
Missouri, Washington, and Wisconsin who exempted their children from at least one 
vaccine, between 57% and 68.6% of them believed vaccinations caused harm to 
children.25 Other concerns reported were fear of overwhelming the immune system, 
believing their child was not at risk for a VPD, belief that natural immunity would be 
superior to artificial immunity, and risk of autism.25 
 In Utah, parents who were seeking philosophical exemptions for their child were 
asked to participate in a study by Luthy et al. regarding reasons for exemption.25 Parents 
were asked to complete a 16 question survey.25 Of the 801 surveys completed, 66.8% of 
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parents reported a concern about safety, including side effects, chronic disease, such as 
autism and epilepsy, and immune system overload.25 287 parents responded to the open 
ended question on the survey regarding their overall vaccine perception.25 Commonly 
listed answers included safety and efficacy concerns, the superior benefit of natural 
immunity and healing methods, and the desire to solidify the need for parental decision 
making.25 This study may not be generalizable to the entire U.S. population as it was 
focused in Utah. The survey used has not yet been validated on other populations.25 
 
Strategies for approaching vaccine hesitant parents  
A cross sectional study done by Opel et al., performed in 9 pediatric practices around 
Seattle, Washington, investigated the types of approaches providers use to communicate 
with VHPs from September 2011 to August 2012.52 The two formats used were 
participatory and presumptive.52 The presumptive interview format “…linguistically 
presupposed that parents would vaccinate, such as declarations that shots would be given 
(eg, “Well, we have to do some shots”)…”55 The participatory format “…linguistically 
provided parents with relatively more decision-making latitude, such as polar 
interrogatives (eg, “Are we going to do shots today?”) and open interrogatives…”55 The 
study enrolled parents of children aged 1 to 19 months who were found to be vaccine 
hesitant on the Parent Attitude about Childhood Vaccine (PACV) Survey.52 The study 
included visits with 16 different providers which were video recorded with specific 
attention to vaccine discussions.52 A total of 55 vaccine discussions were analyzed.52 The 
study found that among all parents, 83% of parents declined vaccine recommendations 
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when the provider began the conversation with a participatory format (p<.001).52 
Meanwhile, 26% declined when the provider began with a presumptive format 
(p<.001).52 For VHPs alone, this continued to be true.52 In the regression analysis, the 
providers’ use of participatory formats in vaccine discussions was associated with a 
significant increase of parental resistance to their recommendations (OR=14.2).52 The 
study also illustrated that in the 19 conversations where the parent demonstrated 
resistance to the provider’s vaccine recommendations, 9 ultimately accepted the 
recommendations at the end of the appointment with persistent counseling.52 This 
showcases the importance of a continued conversation between the provider and parent. 
There are several limitations to this study. First, providers and parents may act differently 
during videotaped conversations than during a normal, private discussion.52 Follow up 
vaccine discussions were not recorded; therefore, the true impact of the conversation 
cannot be assessed.52 The study enrolled parents who were white, English speaking from 
a single geographical location with a known higher socioeconomic status, so the actions 
of the parents may not be generalizable.52 
 Horne et al. investigated the change in vaccine attitude after receiving an 
intervention based on the risks of VPDS.53 The goals of the interventions include showing 
VHPs the risk of their child contracting a VPD was higher than the risk of severe side 
effects from vaccines.53 In this randomly controlled study, participants were assigned to 
the disease risk intervention, autism correction intervention, or a control intervention.53 
Participants in the disease risk group read three informational articles from the CDC’s 
website, including a letter from a mother whose child contracted measles, pictures of 
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children with VPDs, and an article of succinct warnings about the importance of 
vaccines.53 Participants in the autism correction group received information from the 
CDC explaining the research that refutes the association between vaccines and autism.10, 
53 The control group was asked to read about an unrelated scientific topic.53 Before and 
after completing the assigned intervention, participants completed a five item vaccine 
attitude scale to measure their general attitude toward immunization.53 The disease risk 
intervention demonstrated the largest change in pre and post intervention survey scores 
(p=.003, d=.41).53 The study concludes that by focusing on the potential dangers of 
VPDs, providers may be able to persuade parents to vaccinate their children.53 The autism 
correction and control interventions showed similar results, with no significant change 
(p=.017).53 Future studies may be needed to examine the long term effects of these 
interventions.53 
 A study by Masaryk and Hatokova published in the Journal of Health Psychology 
in 2016 reviewed how parents viewed pro-vaccine interventions in Slovakia.19 The study 
participants were divided into two groups.19 The first group consisted of female students, 
ranging from 19 to 26 years old, who were completing an undergraduate course.19 The 
second group consisted of mothers from 26 to 45 years old with children under the age of 
5.19 Each group was spilt into four focus groups.19 All women were white, Slovak 
nationals.19 The four interventions were the same used in Horne et al.19,53 They included 
autism correction, disease risk, disease narrative, and disease images and were focused on 
the MMR vaccination.19 The groups were asked to discuss and rate the messages on 
several topics with a scale of 1 to 5, with one being excellent and five being inadequate.19 
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Both groups rated the messages understandable with a mean of 1.36.19 The mean 
persuasiveness was 2.74 for autism correction, 2.68 for disease risks, 3.61 for disease 
narrative, and 3.36 for disease images.19 Participants in both groups expressed feelings of 
manipulation and emotional blackmail by the disease narrative and images.19 They felt 
the intent of the messages was too obvious which detracted from the goal.18  There were 
reports of participants not understanding how the disease narrative and images related to 
vaccines, because they did not know what diseases the vaccines prevented.19 The four 
interventions focused on the negative effects and publicity related to vaccines and VPDs, 
which created more fear and distrust in the source of the information.19 A more positive 
approach may allow the provider to empower the target audience.19The study may not be 
generalizable to the U.S., as it was performed in Slovakia.  
 
Parent provider interactions    
In the 2009 HealthStyles consumer mail panel survey, parents were asked to list 
the top 3 sources for vaccine information.48 81.7% included their child’s doctor or 
nurse.48 86.5% of the participants reported somewhat or strongly agreeing that they 
typically follow the recommendations of their child’s healthcare provider, and 84% 
agreeing they trust their pediatrician’s advice.48 
A mixed method study performed at Kaiser Permanente Colorado examined the 
parental vaccine decision making process and parent pediatrician trust.55 Seven focus 
groups of twenty four parents total were conducted with VHPs from 2008 to 2010.55 
Parents with children under 4 years old who were under vaccinated or unvaccinated for 
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personal, non medical reasons were included.55 In the second part, 443 participants were 
asked to complete a sixteen question survey, with 9 Likert scale questions and 6 
dichotomous or categorical questions.55 97% of parents who accepted vaccinations 
reported a high level of trust in their pediatrician, while 69% of parents who delayed 
vaccines and 38% of parents who refused vaccines reported the same high level of trust 
(p<.0001).55 Parents who refused vaccines (OR =35.7, p<.001) and delayed vaccines (OR 
8.4, p=.0006) were more likely to have a low level of trust in the pediatrician compared 
to parents who accepted vaccines.55 Of parents who refused vaccines, 26.7% reported 
their pediatrician adequately discussed the risks of vaccines with them, but 88.9% in this 
same group reported the pediatrician discussed the benefits of vaccines (p=.006, 
p=.001).55 For parents who delayed vaccines, 41.7% thought risks were discussed 
appropriately, while 90.2% thought benefits were discussed adequately (p=.006, 
p=.001).55 This may illustrate the benefits of vaccines were not enough to settle parental 
fears about the potential risks of vaccines. 
Wheeler and Buttenheim reviewed the medical record data of 237 provider parent 
interactions of well-baby visits from December 2009 to April 2011 at a private practice in 
an anonymous city to discover more about parental decision making.56 This study showed 
that 19% of parents received vaccine information from family and friends and 21% 
received information from the Internet.56 The majority of parents, 55% received 
information from their children’s provider.56 Medical record analysis showed that parents 
who based their vaccine decisions on non provider based information were associated 
with higher odds of reporting vaccine hesitancy.56 The OR predicting a parent’s intention 
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to use an alternative vaccination schedule for their child was .19 if the parent received 
vaccine information from the doctor and peaked at 10.57 for parents using books as the 
source of information (p<.05, p<.01).56 The study names vaccine information books by 
Dr. Robert Sears as a commonly named source.56 The odds ratio for having no concerns 
when receiving information from the provider was 2.92 (p<.001).56 The odds ratios for 
having no concerns about vaccines when receiving information from family and friends 
and the internet were 0.03 and 0.17, respectively (p<.001, p<.05).56 
A randomized trial was performed in Washington by Henrikson et al. to assess 
whether a communication intervention for physicians could improve their confidence in 
conversations about vaccine hesitancy.57 This two arm clinic level cluster randomized 
trial was performed in 47 outpatient pediatric and family medicine clinics from March 
2012 to December 2013.57 Mothers were contacted postpartum in four hospitals and 
given information about the study.57 Participation was optional for mothers and 
physicians.57 The clinics were randomized into control and interventions groups.57 The 
intervention clinics received a 45 minute specific training session on a new strategy, 
called “Ask, Acknowledge, Advise” developed by Vax Northwest.57 Physicians received 
informational handouts to review and six months of monthly newsletters with a link to a 
webinar version of the training.57 The “Ask” portion of this strategy encourages parents to 
voice questions and concerns.57 During the “Acknowledge” section the physician was 
instructed to establish open communication, show empathy for the parent’s concerns, and 
gain the parent’s trust.57 Then, during the “Advise” portion the physician should state 
their recommendations to the parents and describe the risks and benefits of vaccines.57 
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The control clinics did not receive information on this communication strategy.57 The 
PACV survey was used to measure maternal vaccine hesitancy before and after the 
intervention.57 347 mothers completed the study.57 The intervention had no effect on 
vaccine hesitancy (p =.78). 57 The secondary outcome included measuring the physician’s 
confidence in communicating with VHPs about vaccines with a six single item, self 
efficacy survey before and after the study.57 70% of the control group’s physicians 
reported confidence discussing vaccine hesitancy, compared to 58% of intervention 
group’s physicians at baseline (p=06).57 The intervention showed no significant effect on 
physician self efficacy at the 6 month follow up.57 The limitations of the study by 
Henrikson et al. include that only 67% of the physicians in the intervention group 
attended the training and attendance was only monitored by a sign in sheet; therefore, 
there is not an adequate way to determine if the physicians were properly trained.57 There 
was also no way to track if physicians utilized the online training information.57 The 
study recommends further investigation into communication training of providers with 
long term training and longer follow up intervals to create new habits of communication 
tactics.57 
 
Motivational interviewing  
MI is a form of counseling patients by establishing the patient’s motivation to change or 
form a decision.23,24 Most MI research involves mental health outcomes, however, there 
has been an increased interest in MI for medical care discussions. MI aims to counsel the 
patient through a collaborative partnership between the provider and patient to motivate 
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change.24 There are two main tactical components to MI.24 The relational component is 
described as an “empathetic, affirming, non-judgmental and autonomy –supportive 
counseling style intended to create a safe environment in which clients can explore their 
own wishes, fears, and concerns.”24 The technical component utilizes “strategies aimed at 
eliciting clients’ in session change talk and decreasing their sustain talk with the 
overarching goal of evoking commitment to change.”24 MI is built on the characteristics 
of collaboration, evocation, acceptance, and compassion toward the patient.24 The 
acronym “RULE, Resist, Understand, Listen, and Empower” is used to remember the 
four guiding principles of performing MI.24 Training modules recommend providers 
focus on using open ended questions, positive affirmations when the patient makes a 
change, while reflecting on and summarizing the patient’s concerns and beliefs.24	   	  
A meta-analysis performed by Lundahl et al. in 2013 investigated the efficacy of 
MI in a range of medical care settings for a variety of general medical conditions.58 
Inclusion criteria consisted of randomized studies comparing patients in a medical care 
setting who received MI against patients who didn’t receive MI and must have been 
performed.58 Studies were excluded if the goal of treatment was to aid with addiction or 
behavioral health.58 48 studies were reviewed, with a total of 51 comparisons analyzed.58 
The average length of MI intervention was 106 min with an average of 2.6 sessions.58 
Providers, on average, received 18 hours of MI training.58 MI was shown to have 
statistical significance and a positive impact on 63% of the conditions researched. (Table 
4).58 The overall odds ratio for the 51 comparisons was 1.55 (p value<.001).58 In other 
targeted outcomes, such as decreasing blood glucose, increasing medication compliance, 
	  30 
and increasing safe sex behavior, MI displayed positive odds ratios, but without statistical 
significance.58Targeted outcomes of eating disorders and self care were the only two with 
odds ratios less than 1.58 MI did not have significantly different outcomes in the eight 
different types of medical settings (p=.60).58 The total amount of intervention time 
approached statistical significance (p=.06); however, the meta analysis illustrated the 
number of MI sessions was not associated with positive outcome.58 This may indicate 
that more time spent in one session may be more beneficial than multiple sessions.58 The 
strict inclusion criteria and difference in number of studies per treatment outcome are 
limitations to the study.58  
Table 4. Overall MI effects by Targeted Outcome58 
Targeted Outcome Odds Ratio p-Value 
Decrease in Blood Pressure 1.65 <.001 
Decreasing HIV viral load 2.15 <.001 
Decreasing number of dental caries  1.85 <.001 
Decreasing amount of alcohol use 2.31 <.001 
Decreasing amount of marijuana use  3.22 <.001 
Increasing tobacco abstinence 1.34 <.05 
Increasing quality of life 2.21 <.001 
Self Monitoring  2.14 <.001 
Intention to change 1.97 <.001 	  
Prior to the study described above, Lundahl and Burke reviewed four meta-
analyses in 2009 to explore the value and applicability of MI in clinical practice.59 When 
MI was compared with weak comparison groups, such as no treatment or waitlists, a 14% 
to 20% difference in success was found after an average of two to three MI sessions.59 MI 
compared to strong comparison groups, such as 12 step programs or cognitive behavioral 
therapy showed a 2% to 15% difference, suggesting MI is beneficial, but may not be 
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more beneficial than active treatments.59 The review found MI requires less treatment 
time than other therapies investigated.59 The average MI face to face time was 100 
minutes less than comparison therapies.59 None of the meta analyses showed associations 
between age or gender and positive outcomes.59	  
In a study by Joseph et al. a form of MI, called brief negotiated interviewing, was 
assessed for efficacy of counseling mothers about the benefits of human papillomavirus 
(HPV) vaccine for their daughters.60 The CDC recommend beginning the vaccine series 
for boys and girls between ages 11 and 12.61 The study was a randomized control, pilot 
trial and was performed in Boston, Massachusetts.60 Mother daughter units were recruited 
from April 2011 and September 2013.60 The study includes 100 Haitian American and 
100 African American mother daughter units.60 All daughters had not received a dose of 
the HPV vaccine.60All daughters were between 11 and 15 years old.60 The pairs were 
randomized into control and intervention groups.60 The control group received the 
standard of care, a low literacy HPV informational sheet.60 The intervention group 
received brief negotiating interviewing by trained providers for approximately 20 to 30 
minutes.60 The session focused on the mother’s beliefs and concerns about the vaccine 
and was intended to provide the mother information while being considerate of her 
concerns.60 The primary goal of the study was for the daughters to receive the first dose 
of the HPV vaccine within 1 month of the intervention.60 The proportion of mothers who 
consented to their daughters receiving the first dose was not significantly different, 56% 
in the intervention group and 51% in the control group (p=.47).60 The secondary outcome 
was a change in knowledge about the HPV vaccine among the mothers in the intervention 
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group measured through a pre and post intervention survey.60 The post intervention 
survey demonstrated an increase in the mean score from 6 to 10.2, showing a significant 
difference of 5.3 in HPV vaccine knowledge (p<.0001).60 While vaccination rates did not 
increase, the intervention is a reasonable tactic to increase vaccine knowledge.60 
Limitations of this study include the short follow up time period of only one month. 
Reasons for not scheduling an appointment within a month may have been due to 
socioeconomic factors unrelated to vaccine acceptance.   	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METHODS  
Study design 
 The study is a quality improvement (QI) research project that will seek to evaluate the 
change in vaccination rates for children of VHPs after receiving MI intervention by 
trained healthcare providers. 
 
Study population and sampling 
The parental study population will be recruited from a single pediatric clinic located at 
Boston Medical Center (BMC). Parents of children aged 0 to 6 years old will be eligible 
for the study. The CDC’s recommended childhood immunization schedule includes the 
recommended vaccines for children in this age range.6, 35Appointments with eligible 
children for their respective age appropriate vaccines will be monitored during a six 
month time period for the intervention phase. Visits for children with true medical 
contraindications (Table 2) for the vaccine will be excluded from the study. The parents 
of these children will not receive the MI intervention. All providers, including physicians, 
residents, nurse practitioners, and physician assistants at this clinic will be required to 
participate in MI training and the QI study.   
 
Recruitment 
All parents of children aged 0 to 6 years, who schedule visits at Boston Medical Center’s 
pediatric clinic will be eligible for the study. If the parent demonstrates vaccine hesitancy 
during the appointment, the provider will initiate the MI intervention.  
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Healthcare providers at BMC’s pediatric clinic will be required to attend the MI 
training sessions. The training sessions will be scheduled into normal work hours to avoid 
overtime and inconvenience to the providers.  
 
Intervention 
The study will be organized using the “Plan, Do, Study, Act” model, also known as the 
PDSA model for quality improvement projects.  
 
Plan  
The Healthy People 2020 goal for all children aged 19 months to 35 months old to 
receive DTaP, IPV, MMR, Hib, Hepatitis B, varicella, and PCV immunizations is 
80.0%.62 The current vaccination rate at BMC’s Pediatric clinic for children under 6 
years old is 70%.  This includes DTaP, IPV, MMR, Hib, Hepatitis A, Hepatitis B, 
varicella, PCV, and influenza vaccine acceptance data. The goal for this study will be to 
have a post-intervention vaccination rate of greater than 80% to meet the Healthy People 
2020 goal.62 The project also aims to obtain greater than 50% vaccine acceptance from 
the VHPs after receiving MI by the provider. 
At BMC’s Pediatric Clinic, providers see approximately 350 children per week 
between the ages of 0 and 6 years old. Using this information, it can be estimated that the 
clinic will see 8.400 children in this age range during the six-month intervention phase. 
The clinic has 170 vaccine related visits per week, where children are deemed eligible to 
receive a vaccine. This amounts to 4,080 vaccine related visits over six months. The 
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power calculation using the projected sample size of 4,080 eligible vaccination visits 
during the intervention phase and an alpha of 0.05 projects a post-hoc power of 1.63 
The CDC’s childhood immunization schedule (Appendix) will be used as the 
guide for each provider’s vaccine recommendations. Vaccine hesitant parents in this 
study will be defined as parents who deny age appropriate vaccines for their child. A 
vaccine acceptance occurs when a parent is offered the recommended vaccine(s) for their 
child, aged 0 to 6 years old, and accepts the vaccine. A vaccine refusal will be counted 
when a parent of a child in the same age range refuses the recommended vaccines.  
 
Do 
Prior to the beginning of the study, providers must attend a 1-hour lecture provided by the 
primary investigator discussing the main reasons for refusal of vaccines. This lecture will 
be integrated into the department’s Grand Rounds schedule. The training curriculum will 
be composed of multiple sessions, led by either an MI trainer or the primary investigator. 
The training sessions will include lectures, demonstrations, coaching sessions with small 
group practice, and systematic feedback sessions.64 During the department’s Grand 
Rounds, another 1-hour lecture and demonstration will be given about MI. Two 
additional sessions intended for small group practice and coaching will be held. This 
curriculum will ideally be held over a six-week period. The training sessions will be 
scheduled during regular work hours, with the aim to increase provider enthusiasm and 
compliance. Providers will be required to sign-in to all sessions to monitor attendance. 
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An MI trainer must observe each provider to ensure his or her skills are adequate prior to 
the intervention phase.	  
VHPs will be counseled using MI upon refusing the age appropriate vaccines for 
their child, as recommended by the CDC and WHO.7,36 The time allotment for the 
intervention sessions will be dictated by the clinic’s appointment scheduling and by 
provider discretion. Parents who remain hesitant after MI will be encouraged to return to 
the clinic for additional counseling. There will be no limit on the number of sessions. 
Parents who accept the vaccines will not receive the intervention. The historical 
vaccination rate calculated from the pre-intervention phase will be used as the control. 
  
Study  
This project will measure two main outcomes.  
1) The overall vaccination rates, pre-intervention and post-intervention  
2) The proportion of VHPs who accepted the offered vaccine after the 
intervention 
Data will be collected through a chart review. Prior to MI training, visits of 
children from 0 to 6 years old will be reviewed during the designated six-month time 
span. The vaccination acceptance rate will be assessed. It will include all childhood 
vaccines (Appendix). During the six-month intervention phase of this study, the clinic’s 
overall vaccination acceptance rate will also be assessed through chart review. After the 
intervention phase, the total number of vaccine hesitant parents seen in the clinic will be 
counted. The number of these parents who accept the offered vaccine after receiving the 
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MI intervention will also be counted. The proportion of VHPs who accept the offered 
vaccine after MI will be analyzed.   
Additional data (Table 5) will be evaluated during the retrospective chart review. 
The project will examine whether VHPs  refused all vaccines or specific vaccines. The 
desired use of a modified vaccine schedule compared to following the CDC’s 
recommended vaccine schedule will be monitored. 	  
Vaccination acceptance rates from pre and post intervention time periods will be 
analyzed using a paired t-test to evaluate the change in acceptance. The main focus will 
be the proportion of vaccine hesitant parents who accept the offered vaccine after 
receiving MI.  This will be analyzed with a z-test for proportions. 	  
Table 5. Study Variables and Measures 
 
Pre Intervention  • Historical vaccination acceptance 
rate 
Post Intervention  • Vaccination acceptance rate 
• Total number of vaccine hesitant 
parents seen  
• Number of vaccine hesitant parents 
seen who accepted vaccine after 
receiving intervention  
• Number of vaccine hesitant parents 
seen who declined vaccine after 
receiving intervention  
• Number of MI visits completed by 
a vaccine hesitant parent prior to 
acceptance of vaccine 
• Number of vaccine hesitant parents 
who refuse all childhood vaccines  
• Number of vaccine hesitant parents 
who refuse specific childhood 
vaccines 
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Act  
After the completion of the intervention’s designated time period, the change in vaccine 
acceptance by VHPs will be assessed to determine if MI had a positive impact on 
improving vaccination rates. The clinic’s pre and post intervention vaccination rates will 
be reviewed. Statistical significance of both of these outcomes will be determined. The 
most commonly refused vaccines will be discussed among providers to explore specific 
strategies to help with acceptance. The average number of MI sessions attended per VHP 
who eventually accepted the offered vaccine will be examined to determine if multiple 
sessions should be required for future implementation. Feedback from providers who 
participated in this study will be obtained to see how the MI training or the MI 
intervention could be improved. The MI training curriculum and intervention phase will 
be edited according to this feedback. The project may be re-implemented in an 
appropriate amount of time as determined by feedback. This intervention may continue to 
be repeated as long as the feedback received indicates it remains relevant and effective.  
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Timeline and Resources 
Table 6. Timeline for Study  
June 2017 - August 2017 •  IRB submission and approval  
• Reasons for Vaccine Refusal lecture 
Development 
• MI training Curriculum Development 
September 2017 – November 2017 •  Retrospective Pre Intervention Chart 
Review 
December 2017- March 2018 • Reasons for Vaccine Refusal Lecture 
• MI Training Sessions I-V 
April 2018-September 2018 • Six Month Intervention Phase: MI 
Implementation 
October 2018 – December 2018 • Post Intervention Chart Review 
• Data Analysis 
• Submit manuscript for peer review 
 
 The primary investigator will perform the project’s supervision, chart review, data 
collection, and data entry. A statistician will be hired to assist with data analysis. The 
primary investigator and Motivational Interviewing Network of Trainers (MINT) will 
develop the MI training curriculum. For this study, EMR access for BMC’s Pediatric 
clinic will be required. A MI trainer will also be hired to conduct and organize the MI 
training curriculum.  
Table 7. Budget for QI Study and MI Training	  
Line Item 
Administrative Support 
• Clerical Wages 
• Statistical consulting 
• MINT consulting 
Supplies and Expenses 
• Microsoft Excel 
• Microsoft PowerPoint  
• EMR access  
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Institutional Review Board 
This research QI study will be submitted for review to the Boston University Medical 
Campus IRB for expedited review under the 45 CFR 46. 101 criteria. This study will 
employ new interviewing methodologies. This study will not collect any protected health 
information during the retrospective chart review. All information collected will be 
depersonalized.  	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CONCLUSION 
Discussion 
This study focuses on the relationship between pediatric providers and parents. It aims to 
explore the influential role that healthcare providers have on parental decision making. 
MI has not previously been researched as an intervention for increasing childhood 
vaccination rates. MI encourages nonjudgmental, informative discussions and can be 
used to showcase a common goal of parents and providers, which is to protect children 
and the community from unnecessary risk.  
There are several limitations to this QI research study. First, MI is not an easy 
skill to learn. MI incorporates open dialogue without a predetermined script.24 Providers 
must be able to speak freely and intuitively in response to parental concerns. To master 
MI, the providers must continually practice the skill. Therefore, it could be inferred that 
providers may be more successful in altering vaccination rates the longer they use the 
technique. In this study, patient interactions will not be monitored. The providers’ 
competency in MI will only be directly assessed during training, not during the 
intervention phase. The length of MI intervention will not be monitored. Some parents 
may receive several sessions and others may only receive one. The appropriate 
counseling time needed may be researched at a later date.  
The goal of this QI study is to assess the preliminary success of MI with VHPs 
and increase vaccination rates at BMC’s Pediatric Clinic. The results of this study may 
not be generalizable to all demographics. BMC typically has a diverse population; 
however, the demographics of children and parents will not be recorded.  
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Summary 
Vaccine hesitancy is growing in the U.S.13 Communities with decreased immunization 
rates are associated with a higher risk of a VPD outbreak.13 Efforts should be heightened 
to communicate and educate parents about vaccine safety and benefits. Vaccines are 
victims of their own success.8 Parents who refuse vaccines truly believe they are doing 
what is best for their child, but are commonly misinformed about the pathophysiology of 
vaccines.8 In order to provide the highest level of care, it is vital that providers understand 
why parents refuse or delay vaccine doses for their children.11 The varying reasons 
parents are hesitant to vaccinate their children can not be addressed uniformly.7  
There have been increasing rates of unvaccinated and undervaccinated children in 
the U.S., likely due to the substantial increase in the number of children with nonmedical 
exemptions.25, 26  Many parents, regardless of their vaccine hesitancy status, are concerned 
about the side effects and safety of vaccines.25,26 The field of vaccine hesitancy will 
continue to evolve as parents continue to be misinformed about vaccinations. The reasons 
for refusal may continue to grow as parents are influenced by a wide variety of sources.11, 
42 Parents are found to receive vaccine information from a variety of sources, including 
the Internet, social media, celebrities, books, as well as family and friends.55,56 However, 
the majority of parents describe their child’s healthcare provider as their most trusted 
source of vaccine and healthcare information.55,56 Parents who receive vaccine 
information from a provider are more likely to be compliant with the recommended 
childhood vaccine schedule.48,55,56 
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Many strategies have been attempted to effectively address vaccine hesitancy. A 
provider’s conversations with a VHP can play an integral role in decreasing vaccine 
hesitancy. Poor communication can lead to further rejection of vaccines and the 
dissatisfaction of care.54 The most efficient way to discuss vaccines with parents has yet 
to be determined. Parents have become increasingly inquisitive and involved in their 
children’s healthcare choices. They want healthcare decisions to be a shared 
responsibility between them and the pediatrician.1 Attacking a parent’s beliefs often has a 
“back fire” effect, causing the parents to become more unlikely to vaccinate their child.53 
The majority of Americans are unfamiliar with the symptoms and potentially fatal effects 
of VPDs.19, 53 Parents report feeling their concerns and the specific risks of vaccines are 
not adequately addressed by their child’s provider.55 Meanwhile, providers describe a 
lack of confidence in their vaccine counseling skills.57 Providers are failing to provide 
VHPs with enough evidence and support to change their perspective.19	  
 MI has shown to be beneficial for several medical treatment outcomes, including 
but not limited to decreasing alcohol consumption, increasing tobacco abstinence, and 
reducing blood pressures.58 MI is goal-oriented to alter a specific behavior.59 The 
intervention aims to inspire people to make behavioral changes through collaborative 
relationships with their provider where the patient eventually sees how their current 
behavior does not translate into their future or overall health goals.59 Some studies show 
that MI is as effective as current active therapies for medical health issues, but requires a 
shorter amount of direct interaction.59 Providers who initiate an open dialogue to address 
parental concerns may improve patient satisfaction. The ongoing debate of freedom of 
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choice versus public health protection can be explored and discussed between providers 
and parents.  
This project aims to demonstrate the effectiveness of MI on vaccine acceptance 
and improve the overall patient care provided at BMC’s Pediatric Clinic. By providing a 
quality MI training program, this study aims to increase provider confidence on vaccine 
counseling, improve provider communication skills, educate providers on reasons for 
hesitancy, and improve compliance with the CDC recommended vaccine schedule. An 
unmeasured benefit of the project may be an increase in knowledge of VPDs for parents. 
Providers will also be able to use their new MI skills for other healthcare conversations.  
 
Clinical and/or public health significance 
SAGE believes health communication will be an integral aspect of the success of any 
vaccine promotion project.63 The impact of health communication between providers and 
parents was first demonstrated during the human immunodeficiency virus/acquired 
immunodeficiency syndrome epidemic where there was no treatment and the main tool 
was prevention with social and behavioral changes.63 SAGE concludes that poor 
communication tactics could damage vaccine acceptance among VHPs.63 For a health 
communication strategy to be effective to address vaccine hesitancy, SAGE recommends 
several components.63  First, immunization programs should include proactive and 
methodical communication planning.63 Strategies for providers to respond to VHPs 
should be organized at the onset of any program.63 Second, the program should reinforce 
that provider patient communication is a two way process.63 It is important for providers 
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to understand the parent’s perspective prior to discussing this emotional topic.63 The 
future of the pro-vaccination movement should place emphasis on communication with 
VHPs.41  
The new President of the U.S., Donald Trump, has reportedly asked Robert F. 
Kennedy Jr. to head a potential government commission regarding vaccine safety. Mr. 
Kennedy is known to be anti-vaccinations. He has publically stated he believes that 
vaccines can lead to autism, even though this has been widely discredited.10 The medical 
community fears this may worsen vaccination rates around the U.S. and add to the 
confusion about vaccine safety. It may even lead to mass infectious disease spread with 
reemergence of VPDs because of lower vaccination rates. Providers must be on high alert 
during this political change to continue to protect children and susceptible communities.	  
The recent presidential election highlighted the advantages and disadvantages of the ever-
increasing information technology. Our society has access to information from a 
seemingly limitless number of resources without a means to check on the reliability or 
credibility of the information. Medical professionals must remain engaged with their 
community and be cognizant of the information proliferating over the Internet so they 
may continue to provide care and education based on the best objective medical science 
available. Increasing awareness and learning efficient strategies for these frank 
discussions is extremely important, as all providers must educate patients about the 
benefits and successes of vaccines for all age groups. 	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APPENDIX 
Figure 1: Recommended Immunization Schedule 36 
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